By Ana Espino | Published on March 16, 2026 | 3 min readOsteoporosis is a systemic disease
characterized by reduced bone mineral density and deterioration of bone
microarchitecture.
Vertebral fractures account for approximately 4
0% of
osteoporotic fractures and are frequently asymptomatic, with underdiagnosis
rates reaching up to
60%. Their occurrence increases the risk of subsequent
fractures by nearly fivefold.
Current risk assessment tools, such
as
FRAX, show limited sensitivity for predicting vertebral fractures
specifically, particularly at early stages. These tools mainly incorporate
static clinical risk factors and include few dynamic biological markers.
Chronic low-grade inflammation plays
a central role in the pathophysiology of osteoporosis. The
neutrophil-to-lymphocyte ratio (NLR), a simple and accessible marker of
systemic inflammation, has been proposed as a potential predictive biomarker.
However, results from observational studies remain heterogeneous.
This systematic review and
meta-analysis, published in 2026 in Frontiers in Endocrinology, aimed to
quantitatively assess the association between NLR and the risk of vertebral
fracture in patients with osteoporosis.
Does a high NLR increase fracture
risk?
This meta-analysis, conducted
according to PRISMA guidelines and registered in PROSPERO (CRD420251023391),
included six observational studies involving a total of 938 patients. Analyses
distinguished between categorical data (high vs low NLR) and continuous data
(absolute NLR values).
Analysis of categorical variables,
derived from five studies, showed that patients with
elevated NLR had a
significantly increased risk of vertebral fracture. However, substantial
heterogeneity was observed, suggesting important methodological differences
across studies.
Conversely, analysis of continuous
variables based on four studies did not show a statistically significant
difference between fracture and non-fracture groups, with similarly high
heterogeneity.
Sensitivity analysis provided
important insight. Excluding one study (Li et al., 2023) changed the results of
the continuous-data analysis, which then became statistically significant with
disappearance of heterogeneity. This instability highlights the statistical
fragility of conclusions based on continuous data.
Publication bias analyses revealed a
significant bias for categorical data (Egger test p = 0.04), but not for
continuous data.
From a pathophysiological
perspective, NLR reflects the balance between pro-inflammatory neutrophil
activation and lymphocyte-mediated immune regulation. Inflammation stimulates
osteoclastogenesis via the
RANKL pathway, promoting bone resorption and vertebral
fragility.
A promising biomarker, but evidence
remains limited
Osteoporotic vertebral fractures
represent a major clinical challenge due to their high frequency and often
silent presentation. Identifying simple and accessible biomarkers is therefore
an important objective.
This meta-analysis suggests that
elevated NLR is associated with a significantly increased risk of vertebral
fracture when data are analyzed categorically. However, the absence of
consistent confirmation in continuous analyses and the instability of results
limit the strength of the current evidence.
Key limitations include small sample
sizes, the predominance of Asian populations, heterogeneity in NLR thresholds,
variability in fracture diagnostic criteria, and insufficient adjustment for
confounding factors.
Large prospective multicenter
studies with standardized NLR thresholds and rigorous multivariable analyses
will be required to determine the true incremental value of NLR in fracture
risk stratification. With robust validation, NLR could become a complementary
biomarker alongside existing risk assessment tools.
Read next: Probiotics for stronger bones?
About the author – Ana Espino
PhD in Immunology, specialized in Virology
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions through impactful communication.